Economic burden prior to COPD diagnosis: A matched case-control study in the United States

被引:43
作者
Akazawa, Manabu [4 ]
Halpern, Rachel [3 ]
Riedel, Aylin A. [3 ]
Stanford, Richard H. [2 ]
Dalal, Anand [2 ]
Blanchette, Christopher M. [1 ]
机构
[1] Lovelace Resp Res Inst, Ctr Pharmacoecon & Outcomes Res, Albuquerque, NM 87108 USA
[2] GlaxoSmithKline, US Hlth Outcomes, Res Triangle Pk, NC 27709 USA
[3] i3 Innovus, Hlth Econ & Outcomes, Eden Prairie, MN 55344 USA
[4] Univ N Carolina, Dept Hlth Policy & Adm, Chapel Hill, NC USA
关键词
COPD; Cost; Healthcare; Case-control; Epidemiology; Utilization;
D O I
10.1016/j.rmed.2008.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In the United States, chronic obstructive pulmonary disease (COPD) diagnosis is often a lengthy process, and consequently results in delays in treatment in early stages. Disease progression and complication may result in increased levels of healthcare service use. To understand the economic burden of COPD prior to diagnosis in the U.S., trends in utilization and costs during the period before initial COPD diagnosis were compared with matched controls. Methods: A retrospective case-control study was conducted using medical and pharmacy claims data from a large managed care health plan representing a base population of over 30 million covered lives in the U.S. COPD patients with at least 12 months of continuous enrollment and aged 40 years or older were identified In = 28,968) and matched to up to three random controls (n = 81,322) by age, gender, region of plans and index date. Multivariate regression models were used to estimate average incremental service use and cost between COPD patients and controls. Moreover, trends in utilization and costs for the COPD patients were examined over 36 months before diagnosis. Results: CCPD patients used 1.5-1.6 times more inpatient/emergency department (IP/ED) services and office visits compared to control patients. The average incremental annual. costs for IP/ED services, office visits, and medical and pharmacy services were estimated at $550, $238, $1438 and $401, respectively, after adjusting for age, gender, region and comorbid conditions. The 36-month trend analysis showed that CCPD patients' healthcare utilization and costs increased gradually over time, often with a marked increase in the month before CCPD diagnosis. Conclusions: COPD patients in the U.S. consumed substantial healthcare services and costs prior to diagnosis. More timely diagnosis and subsequent treatment may avoid costly healthcare utilization and unnecessary mortality and morbidity post-diagnosis. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:1744 / 1752
页数:9
相关论文
共 38 条
[1]  
*AG HEALTHC RES QU, COM SOFTW VERS 3 0
[2]   Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone [J].
Allen-Ramey, Felicia C. ;
Markson, Leona E. ;
Riedel, Aylin A. ;
Sajjan, Shiva ;
Weiss, Kevin B. .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (08) :1453-1461
[3]  
[Anonymous], GLOB STRAT DIAGN MAN
[4]   Modeling risk using generalized linear models [J].
Blough, DK ;
Madden, CW ;
Hornbrook, MC .
JOURNAL OF HEALTH ECONOMICS, 1999, 18 (02) :153-171
[5]  
BOTTEMA BJA, 1993, DIAGNOSIS CNSLD GEN, P64
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]   The health impact of undiagnosed airflow obstruction in a national sample of United States adults [J].
Coultas, DB ;
Mapel, D ;
Gagnon, R ;
Lydick, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :372-377
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]  
Díez JD, 2003, ARCH BRONCONEUMOL, V39, P203
[10]  
DOMPELING E, 1992, Scandinavian Journal of Primary Health Care, V10, P143, DOI 10.3109/02813439209014052